harde capsules

DRUG2 trials

Sponsors

Epizyme Inc., Prinses Maxima Centrum voor Kinderoncologie B.V.

Conditions

Delayed chemotherapy induced nausea and vomiting (CINV)Relapsed/refractory follicular lymphoma

Phase 3

SYMPHONY-1: A PHASE 1B/3 DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, 3-STAGE, BIOMARKER ADAPTIVE STUDY OF TAZEMETOSTAT OR PLACEBO IN COMBINATION WITH LENALIDOMIDE PLUS RITUXIMAB IN SUBJECTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

RecruitingCTIS2024-510690-16-00

Epizyme Inc.Relapsed/refractory follicular lymphoma

Start: 2022-01-31Target: 226Updated: 2025-06-26

DAVINCY trial: optimal Duration of (fos)Aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial.

RecruitingCTIS2024-517846-32-00

Prinses Maxima Centrum voor Kinderoncologie B.V.Delayed chemotherapy induced nausea and vomiting (CINV)

Start: 2021-12-21Target: 76Updated: 2024-11-15